Xiao-Ling Cheng
Research Subjects
Xiao-Ling Cheng has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anwen Liu
The Second Affiliated Hospital of Nanchang University 1 Department of Oncology Nanchang, PR China
1 shared publication - Jia-Xin Lin
Department of Gynecology, Cancer Center, Sun Yat-sen University, Guangzhou, China
1 shared publication - Jian-Bing Wu
Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, Jiangxi, China
1 shared publication - Ling-Min Liao
Department of Ultrasound, The Second Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication - Long Huang
Department of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, China.
1 shared publication - Min Zheng
Department of Gynecology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.
1 shared publication
Latest Publications
- Open Access
- 27 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 140
Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients
Small cell cervical carcinoma (SCCC) is a rare, aggressive tumor with a poor prognosis. However, information in relation to its treatment is scarce due to the limited numbers of patients. The aim of this study was to establish whether platinum-based combination chemotherapy may by beneficial in this patient population.
- 27 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 140
Open AccessAnalysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients
Small cell cervical carcinoma (SCCC) is a rare, aggressive tumor with a poor prognosis. However, information in relation to its treatment is scarce due to the limited numbers of patients. The aim of this study was to establish whether platinum-based combination chemotherapy may by beneficial in this patient population.